/Companies

Neumarker

Founded 2022 · 20 employees on LinkedIn · 1 known investors

Find your way into Neumarker

Sign up to see every warm intro you have to Neumarker

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neumarker team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.

Founders & leadership

Neumarker was founded in 2022 by Ken Wang and Qiang Li.

KWKen Wang
Ken WangFounder, Chairman, and Chief Executive OfficerExecutive Officer, Director at Telesair
QLQiang Li
Qiang LiCo-founder and Chief Technology OfficerHe previously held a Vice President of Engineering role in software development, with expertise in embedded software, mobile applications, and Unix/Linux systems.

Investors · 1

Frequently asked questions

What does Neumarker do?
Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
Who founded Neumarker?
Neumarker was founded by Ken Wang, Qiang Li in 2022.
Who are Neumarker's investors?
Neumarker's investors include Foothill Ventures.